Long-term Performance of Laboratory-developed LC-MS/MS Tests and an FDA-approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus

AbstractBackground:Laboratory-developed tests (LDTs) are analytical tests developed and validated “in-house” for clinical diagnosis. Regulatory agencies, such as the United States Food and Drug Administration, encourage using regulatory approved assays rather than LDTs. In an ongoing Zortracker ever